Ocugen director receives 170,100 stock options
Ocugen, Inc. director Kirsten Castillo received a grant of stock options as equity compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Ocugen, Inc. director Kirsten Castillo received a grant of stock options as equity compensation. The award covers 170,100 options to buy common stock at an exercise price of $1.22 per share, expiring on June 11, 2036.
The options vest upon the earlier of June 11, 2027 or Ocugen’s next annual meeting of stockholders, provided she continues to serve through the vesting date. Following this grant, she holds 170,100 derivative securities related to common stock.
Insider Trade Summary
Grant/Award: 170,100 shares
Grant/Award
1 txn
Insider
Castillo Kirsten
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 170,100 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 170,100 contracts (Direct)
Footnotes (1)
- F1. The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
Options granted: 170,100 options
Exercise price: $1.22 per share
Expiration date: June 11, 2036
+3 more
6 metrics
Options granted
170,100 options
Stock Option (Right to Buy) grant
Exercise price
$1.22 per share
Stock option strike price
Expiration date
June 11, 2036
Option expiration
Underlying shares
170,100 shares
Common stock underlying options
Post-transaction derivative holdings
170,100 options
Total derivative securities following transaction
Vesting date trigger
June 11, 2027
Latest vesting date if no earlier annual meeting
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, annual meeting of stockholders, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 1.2200"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-11T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
annual meeting of stockholders financial
"Ocugen, Inc.'s next annual meeting of stockholders"
vesting financial
"The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ocugen (OCGN) director Kirsten Castillo report in this Form 4?
She reported receiving a grant of 170,100 stock options tied to Ocugen common stock. These options are a form of equity compensation and were awarded at an exercise price of $1.22 per share, with a long-dated expiration in 2036.
What are the key terms of Kirsten Castillo’s stock option grant at Ocugen (OCGN)?
The grant covers 170,100 options with an exercise price of $1.22 per share, expiring on June 11, 2036. The options relate to Ocugen common stock and represent a right to buy shares in the future if the vesting conditions are met.
When do the Ocugen (OCGN) stock options granted to Kirsten Castillo vest?
The options vest on the earlier of June 11, 2027 or Ocugen’s next annual meeting of stockholders. Vesting is also conditioned on her continued service with the company through the applicable vesting date, as specified in the filing footnote.
How many Ocugen (OCGN) derivative securities does Kirsten Castillo hold after this transaction?
After this grant, she holds 170,100 derivative securities related to Ocugen common stock. This figure reflects the stock options reported in the Form 4 and represents her position following the acquisition transaction disclosed.
Is Kirsten Castillo’s Ocugen (OCGN) transaction a purchase or a compensation grant?
The transaction is a compensation grant, not an open-market purchase. It is coded as a grant or award acquisition, providing stock options at a set exercise price rather than involving immediate cash payment to acquire common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates